Litigation Details for Eli Lilly and Company v. Radius Health, Inc. (D. Del. 2021)

✉ Email this page to a colleague

The small molecule drug covered by the patent cited in this case is ⤷ Sign Up .

Subscribe to access the full database, or Sign Up
Date Filed	Document No.	Description	Snippet	Link To Document
0000-00-00				External link to document
2021-07-08	1	Complaint	action for infringement of U.S. Patent No. 7,517,334 (“the ’334 patent”). This action relates to Radius…COUNT I FOR PATENT INFRINGEMENT (DIRECT INFRINGEMENT OF U.S. PATENT NO. 7,517,334) …COUNT II FOR PATENT INFRINGEMENT (INDUCEMENT TO INFRINGE U.S. PATENT NO. 7,517,334) …judgment that Radius has infringed U.S. Patent No. 7,517,334 by submitting its supplemental submission…NDA submission prior to expiration of U.S. Patent No. 7,517,334; B. A judgment declaring that	External link to document
2021-07-08	4	Patent/Trademark Report to Commissioner of Patents	the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 7,517,334 B2. (twk) (Entered:…2021 10 August 2021 1:21-cv-01003 835 Patent - Abbreviated New Drug Application(ANDA) None	External link to document
2021-08-11	8	Patent/Trademark Report to Commissioner of Patents	the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 7,517,334 B2. (nmf) (Entered:…2021 10 August 2021 1:21-cv-01003 835 Patent - Abbreviated New Drug Application(ANDA) None	External link to document
>Date Filed	>Document No.	>Description	>Snippet	>Link To Document